Jim Cramer's Top Takeaways: Celgene, Gilead Sciences, Regeneron, Alarm.com, Transunion

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Did you miss last night's "Mad Money" on CNBC? If so, here are Jim Cramer's top takeaways for today's trading. CELG data by YCharts Celgene , Gilead Sciences and Regeneron : With the uncertainty in Europe continuing for what seems like forever, Cramer reiterated that investors need to look for stocks that can transcend the European malaise, stocks like the biotechs, which trade on their ability to meet unmet medical needs and not on global politics.

Topics:  mad money   mad money   mad money   mad money   screener   new york thestreet     did   celgene   gilead sciences   regeneron   european   alrm price   tru price   transunion has   booyah   drugs   jim cramer's    cramer   cramer   cramer's   cnbc   jim cramer   celg   ycharts   europe   alarm   transunion   ipo   click   company   profitable   data   trading   equity   billion   private   stocks   week   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News